ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Research progress of ferroptosis in glaucoma and optic nerve damage

Huang, Sijia; Liu, Kexin; Su, Ying; Wang, Feng*; Feng, Tao哈尔滨医科大学; 1
Molecular and Cellular Biochemistry2023-4DOI: 10.1007/s11010-022-04545-7
1被引3阅读
引用收藏
分享

摘要

Unlike other death forms, such as autophagy, necrosis, and apoptosis, ferroptosis is a novel type of programmed cell death with iron-dependent properties. Esteroxygenase affects the content of unsaturated fatty acids and promotes lipid peroxidation. In addition, GSH can cause the reduction of GPX4, which can cause ferroptosis. P53 and its signaling pathways also regulate ferroptosis. Recent studies have confirmed that ferroptosis also promotes the death of RGC. The progressive loss of RGC is one of the pathological features of glaucoma, indicating that ferroptosis may be related to the onset of glaucoma. Down-regulation of GPX4 leads to the loss of nerve cells, which suggests that ferroptosis may also be related to diseases related to optic nerve damage. At present, ferroptosis has been extensively researched and advanced in systemic diseases, such as cardiovascular diseases, gastrointestinal tumors such as stomach, liver, and pancreas, and brain diseases. This review focuses on the research progress of ferroptosis in ophthalmic diseases, especially glaucoma and optic nerve damage.

学科与关键词

关键词
FerroptosisGlaucomaOptic nerve damageRGC
相关
加载中…
  • Ferroptosis: mechanisms and advances in ocular diseases
    Liu, Kexin; Li, Huazhang; Wang, Feng*; Su, YingMolecular and Cellular Biochemistry, 2023, 478(9): 2081-2095.被引 1
  • GPX4-independent ferroptosis-a new strategy in disease's therapy
    Ma, Tianyu; Du, Jingtong; Zhang, Yufeng; Wang, Yuyao; Wang, Bingxuan; Zhang, Tianhong*Cell Death Discovery, 2022, 8(1): 434.被引 22
  • The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review
    Liu, Meng; Kong, Xiao-Yu; Yao, Yuan; Wang, Xin-An*; Yang, Wei; Wu, Hui; Li, Song; Ding, Jia-Wang; Yang, JianAnnals of Translational Medicine, 2022, 10(6): 368.被引 45
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular and Cellular Biochemistry
发表日期
2023-04
卷期
第 478 卷, 第 4 期
页码
721-727
DOI
10.1007/s11010-022-04545-7
语言
ENGLISH
成果收录
SCIE

作者

  • H

    Huang, Sijia (第一作者)

    harbin med univ

  • L

    Liu, Kexin

    harbin med univ

查看全部 5 位作者收起作者
  • S

    Su, Ying

    1 · harbin med univ

  • W

    Wang, Feng (通讯)

    harbin med univ

  • F

    Feng, Tao

    hosp heilongjiang prov

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417